Several procaryotic organisms have been reported to be resistant to the glutamine analog azaserine (O-diazoacetyl-L-serine) (1, 17) . Resistance to the antibiotic is thought to be the result of a decreased rate of uptake of azaserine by the cells (1, 2, 16) . In Salmonella typhimurium, resistance to azaserine has been reported to be the result of a mutation in the aroP gene, whose product is involved in the general aromatic amino acid transport system (1) . However, a mutation in the dhuA gene, whose product is involved in the regulation of histidine transport, results in the organism acquiring sensitivity to the antibiotic even when the organism harbors a lesion in the aroP gene (2) . This implies that the antibiotic may be transported by multiple transport systems.
Previously we reported that there are at least three levels of resistance to azaserine in Escherichia coli K-12 (17) . Transductional analyses indicate that all spontaneously arising azaserineresistant mutants harbor a lesion in the aroP gene, but that this lesion is not solely responsible for resistance to the antibiotic in E. coli (16) .
This report describes the mapping of a gene (azaA) which is involved with intermediate and high-level resistance to azaserine, and the mapping of a second gene (azaB) which is involved in high level resistance to the antibiotic. Transport studies demonstrate that mutants which harbor a lesion in the azaA gene are not defective in the transport of the aromatic amino acids, but mutants with lesions in the azaB gene are defective in the transport of phenylalanine. 
MATERLALS AND METHODS
Organisms. E. coli K-12 strains used in this study are listed in Table 1 . The genotypes aroP azaA and aroP azaB denote organisms which phenotypically exhibit an intermediate level of resistance to azaserine (minimal inhibitory concentration of 4 x 10-4 M), and the genotype aroP azaA azaB denotes organisms which phenotypically exhibit a high level of resistance to azaserine (minimal inhibitory concentration of >1 x 10' M). Only organisms that possess these genotypes exhibit an intermediate or high level of resistance to azaserine; all other organisms used in this study exhibit a low level of resistance to the antibiotic (minimal inhibitory concentration of 7 x 10-M). The methods employed for the isolation of azaserine-resistant mutants have been described previously (17) . These methods consist of isolating resistant organisms from the zones of inhibition caused by azaserine, or passaging organisms in media which contain successively higher concentrations of azaserine.
Chemicals. Azaserine was purchased from Calbiochem. 5-Methyltryptophan and,-2-thienylalanine were obtained from Sigma Chemical Co. All chemicals were of the highest purity available. L-[U-_4C]tyrosine Media and growth conditions. The minimal medium of Davis and Mingioli (8) was supplemented as required with a 10-ILg/ml concentration of the appropriate amino acids, vitamins, purines, and pyrimidine, except for histidine, which was added to a final concentration of 50,g/ml. All media contained thiamine at a concentration of 10 (10) , with the exception that the membranes which supported the mating cells were incubated in soft Penassay medium rather than soft minimal medium. After incubation, the mating pairs were separated by vigorous mixing in minimal medium containing streptomycin sulfate and the nutrient requirements of the recipient. To allow for phenotypic expression of azaserine resistance, recombinants were incubated with shaking for 3 h. Samples were then plated onto minimal agar containing 0.1 mM azaserine or onto minimal agar containing 0.1 mM /1-2-thienylalanine and 0.2 mM 5-methyltryptophan, which is selective for aroP recombinants.
Transductional procedure. All transductions were performed using modifications of the procedure described by Miller (11) for P1 transduction. The modifications consisted of growing the cells in minimal medium rather than L-broth and then plating the phage-bacterial suspensions directly onto minimal agar instead of a soft minimal overlay.
Transport procedure. The transport of the aromatic amino acids was determined by using the procedure of Whipp and Pittard (15) . Cells were grown in minimal medium containing the necessary growth requirements for at least two doublings. Turbidity was monitored by using a Bausch and Lomb Spectronic 20 spectrophotometer at a wavelength of 560 nm. Cells were harvested in mid-exponential phase of growth by centrifugation, washed twice in minimal medium, and suspended in this medium containing chloramphenicol (80,g/ml) and the specific growth requirements. The cells were incubated at 37°C for 10 min and then stored at 4°C until used.
Cells were brought to 30°C, and the assay was initiated by adding the radioactively labeled amino acid. Samples (0.1 ml) were withdrawn from the reaction mixture at various times after initiation of the assay, passed through membrane filters of pore size 0.45,um, and washed with two 2-ml volumes of minimal medium at 30°C. The filters were dried, 7.5 ml of scintillation solution [600 ml of toluene, 400 ml of 95% ethanol, 5 g of 2.5 diphenyloxazole, and 0.3 g of 1,4 bis-2-(5-phenyloxazolyl) benzene per liter] was added, and radioactivity was determined using a Beckman liquid scintillation counter, model LS 100.
The aromatic amino acids (['4C]phenylalanine specific activity, 10,uCi/,mol; ['4C]tyrosine specific activity, 10 LCi/imol; and [3H]tryptophan specific activity, 2.5 ttCi/4mol) were used at a final concentration of 10 MM, which is saturating for both the common and specific aromatic amino acid transport systems (6) . Control filtrations (without cells) were performed with each experiment to correct for background radiation and nonspecific adsorption of radioactive material to the filters. Corrected values are expressed as nanomoles of amino acid transported per minute per milligram of protein. Protein was determined by using the modified Lowry procedure described by Hartree (9) . RESULTSient, and azaserine resistance was recovered 56 min after mating. A similar phenomenon was observed in conjugational analyses employing high-level resistant mutants.
These results indicated that multiple genes were involved in azaserine resistance. To determine more accurately the location of the genes involved with azaserine resistance, various strains harboring a lesion in the aroP gene were constructed and employed as recipients in various conjugation experiments. A second gene, designated azaA, which is involved with intermediate-level resistance, was shown to map near the hisG gene (min 44).
With regard to high resistance, a third gene designated azaB was shown to map near argG (min 68). However, only recombinants that had a genotype of aroP azaA azaB exhibited a high level of resistance to the antibiotic.
Mapping of azaA gene by transduction.
The azaA gene cotransduced with a frequency of 52% (183/351) with the hisG+ gene and with a frequency of 47% (167/359) with the uvrC' gene. Using the formula of Wu (18), it was possible to calculate that the azaA gene mapped 0.7 min and 0.54 min from the hisG+ and uvrC' genes, respectively (Fig. 1) . The position of the azaA locus relative to the hisG and uvrC loci was confirmed by three-factor analyses ( Table  2 ). The lowest frequency in the first cross was observed in the transductant having the genotype uvrC' hisG+ azaA+. Assuming that this genotype is the result of a double crossover within the transducing fragment, then the gene order is uvrC azaA hisG. This was confirmed by the data obtained with selected hisG+ transductants. Thus the azaA gene maps near min 43 on the E. coli chromosome.
Mapping of the azaB gene by transduction. The azaB gene cotransduced with a frequency of 14% (21/140) with the argG gene and with a frequency of 71% (100/140) with the aspB gene. It was calculated that the azaB gene mapped 0.94 and 0.22 min from the argG and aspB genes, respectively (Fig. 2) of the azaB gene was confirmed by three-factor analyses ( Table 3 ). The lowest frequency in the first cross was argG+ aspB azaB. Since the donor carried argG' and azaB and the recipient aspB, it demonstrates that the aspB locus lies between argG and azaB. The gene order argG aspB azaB was confirmed by the additional data listed in Table 3 .
Cross-resistance studies. Strains were examined for their resistance to azaserine and 5-methyltryptophan by using a standard disk assay (Table 4) . 5-Methyltryptophan is normally transported by the common aromatic permease system. However, by incorporating phenylalanine and tyrosine (10 ,uM) into the medium, the transport of the analog by the common system is blocked, and the analog is then transported by the tryptophan-specific transport system (12) . Also, phenylalanine and tyrosine cause a repression in the synthesis of intermediates in the aromatic amino acid pathways, resulting in an increased sensitivity of the organism to 5-methyltryptophan due to the decreased synthesis of tryptophan by the cell (12) .
Strains that are resistant to azaserine, for example UTH7055, were also resistant to 5-methyltryptophan when grown in minimal medium but sensitive to 5- (1, 4, 5) . Ames reported that aroP mutants of S. typhimurium were obtained by isolating spontaneously arising mutants which were resistant to azaserine, and concluded that the antibiotic was transported by the general or common aromatic amino acid transport system but not by the specific aromatic amino transport systems (1) . However, additional studies demonstrated that strains which harbor lesions in the dhuA and aroP genes are sensitive to azaserine (2) . The dhuA gene product is in- volved in the regulation of the high-affinity transport system. This indicates that azaserine may be transported by the general aromatic amino acid transport system and the high-affmity histidine transport system in S. typhimurium.
Previously it was reported that azaserine inhibited the growth of E. coli, and that of all the aromatic amino acids, only L-phenylalanine could reverse this growth inhibition (5, 17). There was an inverse relationship between the level of azaserine resistance versus the initial rate of uptake of phenylalanine and the efflux of the amino acid from the cell (16) . The greater the level of resistance to the antibiotic, the lower the rate of phenylalanine uptake.
Results of this study demonstrated that intermediate resistance to azaserine is the result of a two-step mutation involving both the aroP and azaA genes. The azaA locus mapped near min 43 on the E. coli chromosome. A gene (tyrP) whose product has been reported to be involved with the tyrosine-specific transport system has been reported to lie near min 44 (15). We do not know whether these loci are identical, and we have been unable to obtain tyrP strains. However, since tyrosine has no effect in reversing the growth inhibition in E. coli caused by azaserine, and since strains that harbor a defective azaA gene are not defective in tyrosine transport, it has been concluded that these mutations represent separate loci.
High resistance to azaserine is the result of lesions in the aroP, azaA, and azaB loci. Genetic analyses demonstrated that the azaB locus lies approximately 0.5 min from a gene (mtr)
whose product is involved with the tryptophanspecific transport system. The fact that these loci are different is supported by cross-resistance studies which demonstrated that it is possible to phenotypically distinguish azaserine-resistant strains from strains that are defective in the tryptophan-specific transport system, based upon their resistance to azaserine and 5-methyltryptophan. Strains harboring a defective mtr locus are sensitive to azaserine when grown in either minimal medium or minimal medium containing phenylalanine and tyrosine. Also, these strains are sensitive to 5-methyltryptophan when grown in minimal medium, demonstrating that they possess a functional aroP gene. However, when these strains are grown in minimal medium containing sufficient concentrations of phenylalanine and tyrosine to saturate the common aromatic amino acid transport system, they are resistant to 5-methyltryptophan, demonstrating that they harbor a defective mtr gene. The converse is true with azaserine-resistant strains. These strains are resistant to azaserine regardless of the medium on which they are grown, and the diameter of the zone of inhibition correlates to the level of azaserine resistance exhibited by these organisms. Mutants resistant to azaserine were resistant to 5-methyltryptophan when grown on minimal medium, demonstrating that they harbored a lesion in the aroP gene, but when these strains were grown on minimal medium containing phenylalanine and tyrosine they were sensitive to 5-methyltryptophan, demonstrating that they possessed a functional tryptophan-specific transport system. Transport analyses further demonstrated that strains possessing a defective azaB gene were not defective in the transport of tryptophan by the tryptophan-specific transport system. However, these strains were defective in the transport of L-phenylalanine. The rate of uptake of phenylalanine in strain MW1065 was 34% of that found in the control. This effect was due to the defective azaB gene and not to the azaA gene, since it has been demonstrated that strains with a defective azaA gene have normal transport rates for the aromatic amino acids. Whipp et al. (14) have described a gene they designatedpheP, whose product is involved with the phenylalanine-specific transport system. They state that this gene maps at a different location from the tyrP and aroP genes, but no mapping data are given. It is possible that the azaB and thepheP genes are the same; however, we have been unable to obtain these pheP strains.
Strains that exhibit an intermediate level of resistance to azaserine can possess the genotype aroP azaA or aroP azaB, and these strains can be distinguished by genetic or transport analyses. The mechanism of resistance to azaserine is different for these strains, depending on the genotype. Strains possessing the aroP azaB genotype are resistant due to a decreased ability to transport the antibiotic, and aroP azaA strains are resistant possibly due to a more rapid efflux VOL. 143, 1980 on July 10, 2017 by guest http://jb.asm.org/ of the antibiotic from the cell. Although it is possible to construct strains having the genotype aroP azaB, none has been isolated as a spontaneously arising azaserine-resistant mutant. Thus there is some natural selective mechanism that favors the fornation of the aroP azaA genotype in strains that exhibit an intermediate level of resistance to the antibiotic.
Brown (6, 7) proposed that, by employing different analogs, it might be possible to isolate mutants defective in the aromatic amino acid uptake as a result of the mutational effects on different macromolecular elements of the general or specific aromatic amino acid transport systems. This was verified in that mutants of both E. coli (6, 7, 12) and S. typhimurium (1, 2, 13) have been isolated using,8-2-thienylalanine, indole acrylic acid, and azaserine. These mutants all have defective aromatic amino acid transport systems, and the lesions have been shown to lie at different locations on the chromosome.
The data presented in this report demonstrate that resistance to azaserine in E. coli is more complex than originally proposed. Azaserine is transported by both the common aromatic amino acid transport system and the phenylalanine-specific transport system, indicating that the antibiotic affects different macromolecular elements of the aromatic amino acid transport systems. Resistance to azaserine is due in part to a decreased rate of uptake of the antibiotic by the cell. Studies are presently under way to elucidate the role of the azaA gene product in azaserine resistance and in aromatic amino acid transport.
